Japan
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
50.06%
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
2 |
48.66%
|
Dec. 31, 2023 | USD 9.76 | -1.43% |
|
Japan |
|
3 |
32.20%
|
Dec. 31, 2023 | USD 13.83 | -0.63% |
|
Japan |
|
4 |
24.77%
|
March 31, 2024 | USD 25.51 | -0.96% |
|
Japan |
|
5 |
24.56%
|
March 31, 2024 | USD 3.56 | -3.55% |
|
Japan |
|
6 |
18.70%
|
March 31, 2024 | USD 10.09 | 0.15% |
|
Japan |
|
7 |
12.18%
|
March 31, 2024 | USD 9.76 | -1.53% |
|
Japan |
|
8 |
11.58%
|
March 31, 2024 | USD 11.15 | -1.27% |
|
Japan |
|
9 |
-5.88%
|
Dec. 31, 2023 | USD 2.56 | -2.54% |
|
Japan |
|
10 |
-11.31%
|
June 30, 2024 | USD 1.03 | -3.60% |
|
Japan |
|
11 |
-12.77%
|
Dec. 31, 2023 | USD 1.21 | 1.57% |
|
Japan |
|
12 |
-210.70%
|
March 31, 2024 | USD 0.17 | -10.87% |
|
Japan |
|
13 |
-636.86%
|
March 31, 2024 | USD 0.90 | -0.59% |
|
Japan |
|
14 |
-3,061.16%
|
Dec. 31, 2023 | USD 3.68 | -3.46% |
|
Japan |
|
15 |
-1,619,147.22%
|
March 31, 2024 | USD 0.28 | -0.59% |
|
Japan |
The Vaccines company in Japan with the highest EBITDA Margin is Shionogi & Co., Ltd. (Tokyo Stock Exchange: 4507.T) at 50.06%.
The Vaccines company in Japan with the lowest EBITDA Margin is BrightPath Biotherapeutics Co., Ltd. (Tokyo Stock Exchange: 4594.T) at -1,619,147.22%.
The top 10 Vaccines companies in Japan by EBITDA Margin are Shionogi & Co., Ltd., Mizuho Medy Co.,Ltd., PeptiDream Inc., Kissei Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., Santen Pharmaceutical Co., Ltd., Astellas Pharma Inc., WDB Holdings Co., Ltd., RaQualia Pharma Inc. and Soiken Holdings Inc..
The bottom 10 Vaccines companies in Japan by EBITDA Margin are BrightPath Biotherapeutics Co., Ltd., Oncolys BioPharma Inc., NanoCarrier Co., Ltd., OncoTherapy Science, Inc., SymBio Pharmaceuticals Limited, Soiken Holdings Inc., RaQualia Pharma Inc., WDB Holdings Co., Ltd., Astellas Pharma Inc. and Santen Pharmaceutical Co., Ltd..